SARC-CalF在养老院居民中筛查肌少症的依据
本研究为横断面研究,以80名养老院居民为对象,用EWGSOP标准诊断肌少症,并验证SARC-CalF筛查工具的效能。结果显示SARC-CalF敏感度77.4%、特异度89.8%,AUC为0.84(95%CI 0.74–0.94),提示其可作为养老院肌少症筛查的有用工具。
要点
- SARC-CalF筛查养老院居民肌少症敏感度77.4%、特异度89.8%。
- SARC-CalF的AUC为0.84(95%CI 0.74–0.94)。
- SARC-CalF可作为养老院肌少症筛查的有用工具。
核心结论
- SARC-CalF可能是养老院居民肌少症的有用筛查试验,将其纳入筛查可为当前养老院预防措施提供额外价值。
研究设计与样本
- 横断面研究,样本为80名养老院居民,其中男性占30%,平均年龄84.3(7.9)岁。
主要发现
- 用EWGSOP诊断标准评估的肌少症患病率为38.7%,用SARC-CalF筛查试验评估的为36.2%。
- SARC-CalF的敏感度为77.4%,特异度为89.8%。
- SARC-CalF的受试者工作特征曲线下面积为0.84(95%CI 0.74–0.94)。
关键数值与推荐
- 肌少症诊断采用EWGSOP标准,其中肌肉量用生物电阻抗测量,肌力用握力测量,躯体功能用常规步速和简易体能状况量表评分评估。
- SARC-CalF筛查试验用于评估肌少症。
临床怎么用
- 在养老院居民中可考虑使用SARC-CalF作为肌少症筛查工具,其敏感度和特异度均较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcopenia is a major health problem of the older population. The European Working Group on Sarcopenia in Older People (EWGSOP) developed diagnostic criteria for diagnosis of sarcopenia that require assessing muscle mass and strength or physical performance. Recently, however, a rapid screening method SARC-CalF was developed. OBJECTIVE: The aim of the present study was to validate the SARC-CalF test using EWGSOP sarcopenia diagnostic criteria in a sample of nursing home residents. METHODS: Cross-sectional study. A sample of 80 nursing home residents [30% of men; mean age 84.3 (7.9) years]. Sarcopenia was determined as proposed by the EWGSOP diagnostic criteria, whereby muscle mass was measured by bioelectrical impedance, muscle strength by handgrip strength, and physical performance by usual gait speed and a Short Physical Performance Battery score. Sarcopenia was also assessed by the SARC-CalF screening test. RESULTS: A total of 38.7% of sarcopenia was evaluated using EWGSOP diagnostic criteria and 36.2% using the SARC-CalF test. The SARC-CalF demonstrated a sensitivity level of 77.4% and specificity of 89.8%. The area under the receiver operating characteristic curves of SARC-CalF test was 0.84 (95% confidence interval 0.74, 0.94). CONCLUSIONS: SARC-CalF could be a useful screening test for sarcopenia in nursing home residents. The incorporation of the test as a basis for sarcopenia screening will provide additional value to current nursing home preventive measures.
引用
- Urzi F, Šimunič B, Buzan E, et al. Basis for Sarcopenia Screening With the SARC-CalF in Nursing Homes. J Am Med Dir Assoc. 2017. PMID: 28866357. doi:10.1016/j.jamda.2017.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。